Affiliation:
1. Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria.
Abstract
This study was designed to investigate effect of artesunate on blood parameters in female rats. Ten female Wistar rats (130 – 150 g) were grouped into control and artesunate (1.43 mg/kg) – treated groups for blood assay. The artesunate was administered orally for 50 days. Hematological assay was carried out using hemocytometer, while biochemical assay was carried out using spectrophotometry. Mean +/- SEM and student’s t-test at p<0.05 were determined. Artesunate (1.43 mg/kg) significantly reduced RBC, platelet and lymphocyte counts when compared to their controls. It also significantly decreased total protein, ALT and ALP values relative to their controls. However, it induced no significant changes in the PCV, Hb, TWBC, neutrophil, monocyte, eosinophil, MCV, MCHC, MCH, albumin, globulin, AST, BUN and creatinine values relative to their controls. Conclusively, it can be suggested that artesunate had both harmful and advantageous effects on blood parameters in female rats.
Publisher
Oriental Scientific Publishing Company
Reference43 articles.
1. 1. World Health Organization. Artesunate. March 2013. Archived from the original (PDF) on 28 December 2013. Retrieved 7 December 2016.
2. 2. World Health Organization. Rectal artesunate for pre-referral treatment of severe malaria. Global Malaria Programme (Report). World Health Organization, 2018.
3. 3. Rosenthal P.J. Artesunate for the treatment of severe falciparum malaria. The New England J. Med., 2008; 358 (17): 1829–1836.
4. 4. Kovacs S.D, Rijken M.J and Stergachis A. Treating severe malaria in pregnancy: a review of the evidence. Drug Safet., 2015; 38 (2): 165–181.
5. 5. Li G., Li Y., Li Z. and Zeng M. Artemisinin-based and other antimalarials: detailed account of studies by Chinese scientists who discovered and developed them. Academic Press, 2017; ISBN 9780128132111.